개인 식별 시장 보고서 : 제품 및 서비스, 기술, 용도, 최종사용자, 지역별(2025-2033년)

The global human identification market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2033, exhibiting a growth rate (CAGR) of 10.17% during 2025-2033. There are various factors that are adding value to the market, which include rising applications in healthcare and personal genomics, increasing crime rates and terrorism activities. Besides this, integration of advanced technologies such as fingerprinting and facial recognition is assisting in generating revenue.

Human identification refers to a technique used to analyze the deoxyribonucleic acid (DNA) sample for the identification of individuals and forensic investigation. It consists of body part detectors that assist in detecting lips, face, heads, shoulders, fingerprints, and palms. It also utilizes next-generation sequencing (NGS), capillary electrophoresis, rapid DNA analysis, polymerase chain reaction (PCR), nucleic acid purification, and extraction technologies. Human identification is widely used for criminal identification, overall analytics of human traits, identifying missing persons, casualties of war, disaster victims, and cause and manner of death. It also assists in tracking individual criminal record, identifying traces, and pardoning decisions.

Human Identification Market Trends:

The increasing demand for DNA analysis on account of rising criminal rates across the globe is one of the key factors driving the growth of the market. In line with this, human identification is widely used in forensics, disaster victim identification, and anthropology for eliminating wrongly associated individuals and redirecting resources to more viable avenues of investigation. Moreover, various technological advancements, such as the integration of artificial intelligence (AI) and machine learning (ML), that assists in mapping and recording facial features, obtaining high-quality source samples, and improving system efficiency, are providing an impetus to the market growth. Additionally, recent developments in sequencing technology have enhanced the utilization of capillary electrophoresis (CE) and massively parallel sequencing (MPS) methods for human identification in forensic and paternity testing labs, which, in turn, is positively impacting the market growth. Apart from this, extensive research and development (R&D) activities and the implementation of various government policies to provide funding for forensic programs are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Product & Service:

• Instruments
• Assay Kits and Reagents
• Software and Services

Breakup by Technology:

• Polymerase Chain Reaction (PCR)
• Next Generation Sequencing (NGS)
• Nucleic Acid Purification and Extraction
• Capillary Electrophoresis
• Rapid DNA Analysis
• Others

Breakup by Application:

• Forensic Applications
• Paternity Testing
• Others

Breakup by End User:

• Forensic Laboratories
• Research Centers, Academic and Government Institutes

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Eurofins Scientific, Hamilton Company, Illumina Inc., Laboratory Corporation of America Holdings, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

• 1.How big is the human identification market?
• 2.What is the future outlook of human identification market?
• 3.What are the key factors driving the human identification market?
• 4.Which region accounts for the largest human identification market share?
• 5.Which are the leading companies in the global human identification market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Human Identification Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product & Service

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Assay Kits and Reagents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Software and Services
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Polymerase Chain Reaction (PCR)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Next Generation Sequencing (NGS)
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Nucleic Acid Purification and Extraction
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Capillary Electrophoresis
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Rapid DNA Analysis
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Application

• 8.1 Forensic Applications
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Paternity Testing
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Forensic Laboratories
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Research Centers, Academic and Government Institutes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Agilent Technologies Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Bio-Rad Laboratories Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Eurofins Scientific
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Hamilton Company
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Illumina Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Laboratory Corporation of America Holdings
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 PerkinElmer Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Promega Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Qiagen N.V.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Siemens AG
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis
  • 15.3.12 Thermo Fisher Scientific Inc.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis